Pinnacle Wealth Planning Services, Inc. Ironwood Pharmaceuticals Inc Transaction History

Pinnacle Wealth Planning Services, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$10.14 - $12.38 $608 - $742	-60 Reduced 0.56%	10,603 $109,000
Q2 2022 Aug 03, 2022	BUY	$11.05 - $12.72 $117,826 - $135,633	10,663 New	10,663 $123,000
Q1 2022 Apr 20, 2022	SELL	$10.61 - $12.88 $111,341 - $135,162	-10,494 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$10.86 - $13.95 $673 - $864	-62 Reduced 0.59%	10,494 $122,000
Q3 2021 Oct 29, 2021	BUY	$11.92 - $13.92 $1,907 - $2,227	160 Added 1.54%	10,556 $138,000
Q2 2021 Aug 02, 2021	BUY	$10.16 - $13.11 $447 - $576	44 Added 0.43%	10,396 $134,000
Q1 2021 Apr 29, 2021	BUY	$9.04 - $11.86 $87,895 - $115,314	9,723 Added 1545.79%	10,352 $116,000
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $5,692 - $7,673	629 New	629 $7,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.